While regulatory alignment remains essential, operational urgency driving companies to AI adoption is equally profound. In ...

The pharmaceutical industry has expressed strong opposition to the government’s push for drug price reductions, warning that such a policy—combined with rising oil prices, exchange rates, raw material ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, ...

Karthik Sankaranarayanan trained in two quite different scientific subfields as a graduate student and as a postdoctoral ...

Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce training, and strong infrastructure.

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union. Still, as with previous communications on the ...

The consortium includes Exactmer, GSK, Queen Mary University of London, Atmospheric AI, Solve Chemistry, OXCCU, Celtic Renewables, University of Leeds, CPI, Croda, and Cytiva. The project is backed by ...

Asahi Kasei acquires Aicuris for €780M ($920M), adding anti-infective assets to its transplant and nephrology specialty pharmaceutical platform.

Corden Pharma Colorado Inc., a developer and manufacturer of peptide drug substances, has leased the 64,000-square-foot 5505 ...

Amid the testing regional security situation, Qatar's pharmaceutical manufacturers are pushing back with a show of resilience — running factories around ...

While Nifty Pharma giants struggle with regulatory headwinds and pricing pressures, two outliers are quietly catching the ...